Tailored radiation boosts survival in lung cancer trial

NCT ID NCT07164885

Recruiting now Disease control Sponsor: Capital Medical University Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tests a new way to deliver radiation therapy for people with stage III lung cancer that cannot be removed by surgery. The treatment is personalized based on each patient's tumor sensitivity to radiation. The goal is to see if this approach helps people live longer and keeps the cancer from growing, compared to standard radiation. About 900 adults with this type of lung cancer will take part.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for LOCALLY ADVANCED NON-SMALL CELL LUNG CANCER are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

non-small cell lung carcinoma

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

LOCALLY ADVANCED NON-SMALL CELL LUNG CANCER

Contacts and locations

Show contact details

Study contacts

Contact

Phone: •••-•••-•••• Email: •••••@•••••

Locations

University of Hong Kong Shenzhen Hospital
RECRUITING

Shenzhen, Guangdong, 518000, China

Contact Phone: •••-•••-•••• Email: •••••@•••••